FDA inspection
Lupin Limited: FDA inspection ending Aug 8, 2019
FDA inspection 1102191 · No Action Indicated (NAI) · Nagpur
Key facts
| Inspection ID | 1102191 |
|---|---|
| Firm | Lupin Limited |
| FEI number | 3009843207 |
| Address | Unit 1, Special Economic Zone, Plots 6A1, 6A2, Sector 17 ; Mihan |
| City | Nagpur |
| Country | India |
| Fiscal year | 2019 |
| Inspection end date | Aug 8, 2019 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data